REMS
Contraindicated in:
Use Cautiously in:
Endo: hyperglycemia, inappropriate insulin secretion (with long-term use)
F and E: fluid overload, hypokalemia, hypophosphatemia, hypomagnesemia, hyponatremia
GU: glycosuria
Local: local pain/irritation at IV site (hypertonic solution)
Drug-drug:

Hydration (as 5% solution)
Hypoglycemia
Absorption: Well absorbed following oral administration. IV administration results in complete bioavailability.
Distribution: Widely distributed and rapidly utilized.
Half-Life: Unknown.
(effects on blood sugar in patients with diabetes)patients with diabetes
| ROUTE | ONSET | PEAK | DURATION |
| PO | rapid | rapid | brief |
| IV | rapid | rapid | brief |
NDC Code